Information Provided By:
Fly News Breaks for April 27, 2015
GSK, AGEN
Apr 27, 2015 | 08:46 EDT
After Agenus' (AGEN) partner, GlaxoSmithKline (GSK), published positive, final Phase III trial results for the RTS,S/AS01 malaria vaccine, JMP Securities says the data was positive and validate the QS-21 adjuvant system. The firm reiterates an Outperform rating on Agenus.
News For AGEN;GSK From the Last 2 Days
There are no results for your query AGEN;GSK